Actinogen Medical Ltd has released a press release.
Correction-March2026 quarterly activity report & Appendix 4C
Earlier from Actinogen Medical
- Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
- ACW XanaMIA Alzheimers open label trial commences